08:33 AM EDT, 05/16/2025 (MT Newswires) -- IQVIA ( IQV ) said Friday it formed a collaboration with SCRI Development Innovations, the contract research organization arm of Sarah Cannon Research Institute,, with the aim of accelerating the development of oncology trials for pharmaceutical and biotech partners worldwide.

Financial terms were not disclosed.

Under the collaboration, the two companies will seek to streamline cancer drug trials by enhancing clinical trial processes, remove operational hurdles, and expedite data delivery, the company said.

Shares were 0.6% higher in recent premarket activity.